News
Lincoln Pharmaceuticals consolidated net profit declines 24.12% in the September 2025 quarter
13-Nov-2025 | 15:16
Sales rise 1.33% to Rs 163.36 crore
Net profit of Lincoln Pharmaceuticals declined 24.12% to Rs 19.98 crore in the quarter ended September 2025 as against Rs 26.33 crore during the previous quarter ended September 2024. Sales rose 1.33% to Rs 163.36 crore in the quarter ended September 2025 as against Rs 161.21 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 163.36 | 161.21 | 1 |
| OPM % | 15.57 | 17.60 | - |
| PBDT | 32.43 | 38.01 | -15 |
| PBT | 28.81 | 34.78 | -17 |
| NP | 19.98 | 26.33 | -24 |
Powered by Capital Market - Live News